New Restrictions on Sale and Use of E-Cigarettes in Bacolod City

Oct.26.2023

Boracay City in the Philippines has updated its smoking ban to include restrictions on the sale and use of e-cigarettes.

According to the report by Inquirer, the city of Badong in the Philippines has introduced amendments to the smoking ban ordinance passed in 2012, now placing restrictions on the sale and use of e-cigarettes and e-cigarette liquid products.

The Municipal Public Information Office has announced that the amendment to City Regulation No. 1 in 2012 includes the prohibition of selling and using e-cigarette products in schools, areas near schools, children's entertainment facilities, elevator stairwells, gas stations, hospitals, buses, stations, food preparation areas, public places such as squares, parks and playgrounds, municipal halls, cinemas, and churches.

The PIO further added that the sale of e-cigarette products to minors is strictly prohibited. The revised regulations also mandate the establishment of designated smoking or e-cigarette areas that must be approved by the local Public Health Office (CHO).

The city of Badong will establish a smoke-free task force to oversee enforcement of the regulations. Offenders will face a fine of 1,000 pesos for the first violation, 2,000 pesos for the second violation, and 3,000 pesos plus imprisonment for the third violation. Individuals caught selling e-cigarettes in violation of the regulations will be subject to a fine of 3,000 pesos for the first offense, 4,000 pesos for the second offense, 5,000 pesos for the third offense, as well as imprisonment, and suspension or revocation of their licenses or business permits.

References:

[1] Batangas City restricts sale, use of vape

Also Read:

[1] Philip Morris Philippines Granted Partial Tax Refund on VAT

[2] Midnight Theft at E-cigarette Store Shrouded in Suspicion in Philippines

[3] Philippine Introduces Digital Tracking System for Tobacco Products

[4] Balancing Youth Protection with Adult Smokers: A Call for Better Regulation

#E-cigarette #E-cigarettes and Tobacco #USA

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

PMI Japan to Launch Limited Edition IQOS ILUMA i "Galaxy Blue", Introduces New TEREA Clear Regular Flavo

PMI Japan unveils limited edition IQOS ILUMA i in Galaxy Blue, inspired by the universe, set to launch on October 29.

Oct.14 by 2FIRSTS.ai

Imperial Brands launches ZONE nicotine pouches in the UK, covering the core 9–12 mg strength segment

Imperial Brands has launched its ZONE nicotine pouches in the UK, targeting the mainstream 9–12 mg nicotine strength segment. The brand debuts with five flavours at a recommended retail price of £6.50 per can. Mint variants currently account for around 70% of UK nicotine pouch sales, while fruit flavours are growing rapidly. ZONE will be distributed primarily through independent retail channels.

Nov.18 by 2FIRSTS.ai

U.S FDA Announces Dec. 8 Deadline for IQOS MRTP Renewal Comments

The U.S. FDA has set December 8, 2025, 11:59 p.m. ET as the closing date for public comments on the MRTP renewal applications submitted by Philip Morris Products S.A. for several IQOS heated tobacco products.